Dongbao Bio-Tech released its 2024 annual performance, with a net profit attributable to the parent company of 85.9827 million yuan, a year-on-year decrease of 28.28%
Dongbao Bio-Tech released its 2024 annual report, with operating revenue of 885 million yuan, a year-on-year decrease of 9.19%; net profit attributable to shareholders was 85.9827 million yuan, a year-on-year decrease of 28.28%; net profit excluding non-recurring gains and losses was 79.0893 million yuan, a year-on-year decrease of 28.17%; basic earnings per share were 0.1448 yuan/share. The company plans to distribute a cash dividend of 0.25 yuan (tax included) for every 10 shares
According to the Zhitong Finance APP, Dongbao Bio-Tech (300239.SZ) released its annual report for 2024. The company's operating income for 2024 was 885 million yuan, a year-on-year decrease of 9.19%; the net profit attributable to shareholders of the listed company was 85.9827 million yuan, a year-on-year decrease of 28.28%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 79.0893 million yuan, a year-on-year decrease of 28.17%; the basic earnings per share were 0.1448 yuan/share. It is proposed to distribute a cash dividend of 0.25 yuan (including tax) for every 10 shares
